There was a 76.5% decline in CMS reimbursement for MRI between 2003 and 2025, according to a study published Nov. 4 in Clinical Imaging.
Researchers analyzed CMS fee schedules from 2003 to 2025 and adjusted for inflation based on data from the Bureau of Labor Statistics for the study.
While CMS’ reimbursement decreased “substantially” for all common imaging exams, the decrease was most prominent for MRI, which fell by a mean of $1,004.33 from peak reimbursement during the study period, the study authors wrote.
CMS reimbursement for CT during the study period decreased by a mean of $466.10, or 69.1%.
Read the full study here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
